Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...
MedCity News9d
Could the Trump Administration Change the Medicare Drug Price Negotiation Program?
CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the ...
How Medicare Says It Arrives At ‘Fair’ Prescription Drug Prices
We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...
JD Supra4d
Mintz IRA Update — The Future of the Medicare Drug Price Negotiation Program
The Centers for Medicare and Medicaid Services (CMS) and pharmaceutical drug manufacturers are gearing up for the second ...
Hosted on MSN2d
15 New Drugs Selected for Medicare Price Negotiations
The federal health insurance program has selected 15 additional drugs covered by Medicare Part D for its next round of price ...
CVS Group pres. explains PBMs' vital role in negotiating drug costs
As pharmaceutical companies prepare to meet with the Trump administration to negotiate drug prices, CVS Health (CVS) ...
STAT28d
Medicare drug price negotiations need something new: a floor
Soon, the Centers for Medicare and Medicaid Services will begin the price negotiation process on a new set of 15 drugs. The new Trump administration should seize the opportunity to change the ...
JD Supra4d
Mintz IRA Update — From the Desk of ML Strategies: The Medicare Drug Price Negotiation Program Under the Second Trump Administration
The start of Donald Trump’s second presidency and Republican control in the 119th Congress raises questions about the future ...
Fierce Healthcare20d
Trump's CMS signals flexibility on Medicare drug price negotiation, sparking new questions for RFK Jr.
The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process of negotiating prices for certain Medicare Part D drugs with input ...
Medicare’s next list of drugs for price negotiation could get ‘very interesting’ — and have a bigger impact on pharma
The Biden-era law is now in the hands of a new administration, and drugmakers are scanning the horizon for hints of a massive ...
NBC New York9d
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
President Donald Trump likely won't do away with a process that allows Medicare to negotiate drug prices with manufacturers, even as he erases Joe Biden's other policy accomplishments. But Trump ...